Jonas Willmann, MD (@jonas_willmann) 's Twitter Profile
Jonas Willmann, MD

@jonas_willmann

Radiation Oncologist | Research scholar @MSKCancerCenter and @Unispital_USZ | interested in 🫁, reirradiation & oligometastatic disease

ID: 2408978660

linkhttps://scholar.google.com/citations?user=smUWeEgAAAAJ&hl=en calendar_today24-03-2014 13:00:12

271 Tweet

323 Takipçi

663 Takip Edilen

Jonas Willmann, MD (@jonas_willmann) 's Twitter Profile Photo
Jonas Willmann, MD
@jonas_willmann

a month ago

🫁 Intrathoracic relapse after PACIFIC-regimen for LA-NSCLC remains a major therapeutic challenge. 🧪 In the AUSTRAL trial, led by Matthias Guckenberger & Andrea R. Filippi, we target this unmet need by combining RT (reRT and/or metastatis-directed SBRT) + durvalumab + ceralasertib

🫁 Intrathoracic relapse after PACIFIC-regimen for LA-NSCLC remains a major therapeutic challenge. 🧪 In the AUSTRAL trial, led by <a href="/Mat_Guc/">Matthias Guckenberger</a> &amp; <a href="/AndrearicFili/">Andrea R. Filippi</a>, we target this unmet need by combining RT (reRT and/or metastatis-directed SBRT) + durvalumab + ceralasertib